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Abstract  
BACKGROUND: Cardiac rhabdomyoma (CRs) are the most common primary tumour of the heart in infants and 
children. Usually are multiple and, basing on the location can cause a haemodynamic disturbance, dysrhythmias 
or heart failure during the fetal and early postnatal period. CRs have a natural history of spontaneous regression 
and are closely associated with tuberous sclerosis complex (TSC). It has an association with tuberous sclerosis 
(TS), and in those, the tumour may regress and disappear completely, or remain consistent in size.  
AIM: We aimed to evaluate the prenatal diagnosis, clinical presentation and outcome of CRs and their association 
with TSC in a single centre. The median follow-up period was three years (range: 6 months - 5 years).
 
MATERIAL AND METHODS: We reviewed medical records of all fetuses diagnosed prenatally with cardiac 
rhabdomyoma covering the period January 2010 to December 2016 which had undergone detailed ultrasound 
evaluation at a single centre with limited technical resources.  
RESULTS: Twelve fetuses were included in the study; mostly had multiple tumours and a total of 53 tumours 
were identified in all patients - the maximum was one fetus with16 tumours. All patients were diagnosed prenatally 
by fetal echocardiography. In two patient's haemodynamic disturbances during the fetal period was noted and 
pregnancies have been terminated. After long consultation termination of pregnancy was chosen by the parents in 
totally 8 cases. In four continuing pregnancies during the first year of live tumours regressed. TSC was diagnosed 
in all patients during the follow-up. 
 
CONCLUSIONS: Cardiac rhabdomyoma are benign from the cardiovascular standpoint in most affected fetuses. 
An early prenatal diagnosis may help for an adequate planning of perinatal monitoring and treatment with the 
involvement of a multidisciplinary team. Large tumour size, the number of tumours and localisation may cause 
hydrops, and they are significantly associated with poor neonatal outcome. 
 
 
 
 
Introduction 
 
In 1982, DeVore et al. first reported the 
prenatal diagnosis of a cardiac tumour. With the 
advancement of fetal echocardiography and magnetic 
resonance imaging (MRI), prenatal diagnosis of fetal 
cardiac tumours has become feasible, and the 
number of case series reported has increased in this 
past decade [1].
 
With the estimated incidence 1 in 20,000 
births are the most common fetal cardiac tumour. 
Cardiac rhabdomyoma CRs) are often multiple and 
can represent up to 90% of cardiac tumours in the 
paediatric population 1. The majority are diagnosed 
during the fetal period or before the age of 1 year. 
CRs diagnosed on fetal echocardiography are typical 
of TSC [2]. It may be isolated or associated with other 
specific lesions of TSC, namely cortical tubers and 
subependymal nodules, or, rarely, renal lesions. The 
association of CR with such specific lesions during 
fetal life strongly supports the diagnosis of TSC [2, 3]. 
As cerebral lesions are responsible for the most 
severe clinical manifestations of the disease, such as 
seizures, mental retardation and behavioural 
abnormalities, the neurodevelopmental outcome is a 
critical issue when cerebral lesions are observed 
during fetal life. The absence of a brain or renal 
lesions, however, excludes neither the diagnosis of 
TSC nor the possibility of future neurodevelopmental 
complications, because lesions may develop 
progressively after birth [3, 4]. Tuberous sclerosis 
complex is an autosomal dominant genetic disease 
with an incidence of about 1/6000 to 1/10 000 live 
births. It is characterised by the widespread 
development of hamartomas in different tissues. It is 
caused by mutations in either the TSC1 or the TSC2 
gene, located on chromosomes 9q34 and 16p13.3, 
respectively [5].  
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Table 1: Demographic data of the 12 patients diagnosed cardiac rhabdomyoma
 
Case GA (weeks) Sex Family history Hydrops Termination of 
pregnancy 
Number of 
tumours
 
Tuberous 
sclerosis 
Location Largest diameter 
(mm) 
GA - gestational age; F- female, M-male; IVS - interventricular septum; LV - left ventricle; RV - right ventricle; 
1 17 F none − + Multiple − RV + LV 41 
2 29 M none − − Multiple + RV + IVS 11 
3 26 M + − − Multiple + RV + LV 30 
4 34 F none + − Multiple − RV + LV 34 
5 18 M none − − Multiple + RV + LV 22 
6 18 F − − − Multiple + RV + LV 16 
7 31 F none + − Multiple − RV 14 
8 18 F none − + Multiple − RV 8 
9 20 M − − + Multiple − RV 23 
10 19 F none − + Single − LV 20 
11 19 F − − + Single − LV 20 
12 21 F none − + Single − RV 16 
 
The exact incidence of rhabdomyoma 
coexisting with TS in fetuses is unknown; although an 
estimate of one in 10 000 in routine necropsies of all 
ages was reported. With improved sonographic, MRI 
and molecular analytical technology, a fetal diagnosis 
of cardiac rhabdomyoma may be of great clinical 
significance [3, 6].  
The purpose of this meta-analysis, with the 
addition of 12 cases from our hospital, was to 
evaluate outcome in cases diagnosed with fetal 
cardiac rhabdomyoma using prenatal sonography. 
 
 
Study design 
 
We reviewed the medical records of all cases 
diagnosed prenatally by fetal echocardiography, with 
cardiac rhabdomyoma, between January 2010 and 
December 2016.  
 
 
Results 
 
Twelve fetuses with cardiac rhabdomyoma 
were diagnosed at 21.4 ± 6.0 weeks' gestational age. 
Of ten continued pregnancies, there were two 
spontaneous intrauterine deaths, in 8 cases 
termination of pregnancies was chosen by parents 
and four were delivered at term. Although, of 
continuing pregnancies, none had prenatal 
hemodynamic complications, after birth none had 
cardiac symptoms. Over the same period, all patients 
were diagnosed with cardiac rhabdomyoma 
postnatally. All were referred for cardiac assessment 
after findings suggesting TSC. On follow-up, TSC was 
confirmed in all patients including neurodevelopmental 
disease. The incidence of cardiac symptoms and TSC 
was not statistically different between the prenatal and 
postnatal diagnosis groups.
 
The demographics of the 12 cases of fetal 
cardiac rhabdomyoma from our hospital are shown in 
Table 1. There were nine cases with multiple tumours 
(Figure 1 and 2) and three cases with single tumours 
(Figure 3). 
 
  
Figure 1: Fetus in the 34th gestational week of pregnancy with 
multiple rhabdomyoma – we counted 16 tumours in different heart 
structures
 
 
The mean diameter of the tumour mass at 
detection was 17 (range, 6–29) mm. Seven cases of 
cardiac rhabdomyoma were detected before 20 weeks 
of gestation. Of the four surviving neonates, all were 
associated with TS, and all had multiple tumours. 
There was no survivor when fetal hydrops or fetal 
dysrhythmia occurred.
 
  
Figure 2: Fetus in the 19th gestational week of pregnancy with 
isolated rhabdomyoma 
 
 
Discussion  
 
Cardiac rhabdomyoma are the most common 
fetal cardiac tumours during prenatal and neonatal 
periods, accounting for 60–86% of primary fetal 
cardiac tumours. Prenatally, they are usually 
diagnosed during the second or third trimester [6, 7]. 
 Bejiqi et al. Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma 
 ______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Apr 15; 5(2):193-196.                                                                                                                                                         195 
 
On ultrasound, rhabdomyomas appear as round, 
homogeneous, hyperechogenic masses in the 
ventricles, and they sometimes appear as multiple foci 
in the ventricles and septal wall. Differential diagnosis 
between rhabdomyoma, fibroma or myxoma using 
ultrasonography for a single cardiac mass remains 
difficult. 
 
 
Figure 3: Fetus in the 26th gestational week of pregnancy with 
multiple rhabdomyoma 
 
On the contrary, other primary cardiac 
tumours in fetuses such as teratoma and 
hemangioma are easily distinguishable, both clinically 
and using imaging studies. Hemangiomas show a 
more complex echogenicity, with cystic and solid parts 
mixed with calcifications, and are usually found in the 
right atrium. Teratomas are extracardiac masses that 
are located in the pericardial cavity, always associated 
with pericardial effusion and weakly associated with 
TS. Cardiac complications are rare and mainly involve 
fetal dysrhythmia (brady or tachyarrhythmia), but other 
complications such as intracardiac obstruction and 
cardiac failure also may be associated [8-10].  
The earliest antenatal sonographic detection 
of a cardiac tumour in our study was at 17 weeks of 
gestation whereas half of them were detected after 20 
weeks of gestations.  
The smallest detectable tumour mass was 6 
mm, and the largest was 29 mm in diameter. Although 
the difference was not statistically significant, smaller 
tumours tended to be multiple and a search for more 
tumours when the cardiac mass size is small is 
therefore recommended. In our study, all cardiac 
rhabdomyoma showed an increase in size in utero, 
but rapid growth was uncommon. Both foetuses with 
perinatal death had the tumour mass bigger than ≥ 20 
mm in diameter. Although histologically benign, larger 
tumours carry a greater risk of causing hemodynamic 
disturbances and dysrhythmias, which could result in 
poorer outcome at the fetal age [8, 10, 11]. 
In our cases, we didn't find cardiac or 
extracardiac structural defects. Also, there was no any 
coexistence of cardiac rhabdomyoma with trisomy 21 
or any other chromosomal anomalies.  
CRs may have different presentations and 
clinical course. Surgery is only necessary when a 
hemodynamically significant obstruction is present 
[12].  
As CRs are associated with long-term 
development of TSC and other diagnostic features are 
not yet typically apparent in the prenatal and neonatal 
periods, careful evaluation and follow-up are essential 
to exclude TSC [13].
 
The genetic basis of TS is heterogeneous, 
and TS may be caused by the mutation of the tumour 
suppressor genes TSC1 or TSC2. A genetic method 
of screening for TS patients has not been established. 
Cardiac rhabdomyoma may be the earliest sign of TS 
in utero and precede the detection of brain or kidney 
lesions. TS follows an autosomal dominant hereditary 
pattern with variable expression, and 50–80% of 
childhood cases are considered to result from 
spontaneous mutations. The detection of cardiac 
tumours, which can be achieved using prenatal 
echocardiography, should be used as a warning sign 
for TS during the counselling of at-risk families [2, 3, 
9]. 
Despite the aforementioned limitations on the 
number of cases and lac of MRI investigations, this 
report showed that a positive family history of TS and 
multifocality of fetal cardiac rhabdomyoma are two 
strong predictors of neonatal outcome. Large tumours, 
hydrops and fetal dysrhythmias are usually correlated 
with hemodynamic disturbances, resulting in poor 
outcomes during the fetal life. Fetal echocardiography 
is useful in the detection of cardiac rhabdomyoma, 
providing a clue for the detection of TS.
 
To better predict neurodevelopmental 
prognosis, further investigation is required to evaluate 
the number, size and location of specific cerebral 
lesions in cases that are diagnosed prenatally with 
CR. 
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